Precision Biosciences (DTIL) Cash from Operations (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Cash from Operations data on file, last reported at 11937000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 37.35% year-over-year to 11937000.0 in Q1 2026; TTM through Mar 2026 was 58728000.0, a 0.36% change from a year earlier, with the FY2025 full-year figure at 65843000.0, down 12.66% from the prior year.
• Cash from Operations for Q1 2026 stood at 11937000.0, down from 11250000.0 in the prior quarter.
• Over the last five years, Cash from Operations for DTIL reached as high as 29186000.0 in Q3 2022 and fell as low as 31464000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 15652470.59 across 5 years, with a median of 18981000.0 in 2024.
• Across the five-year window, Cash from Operations soared 222.09% in 2022 and plunged 179.12% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 21843000.0 in 2022, then surged by 61.44% to 8423000.0 in 2023, then sank by 121.81% to 18683000.0 in 2024, then surged by 39.78% to 11250000.0 in 2025, then dropped by 6.11% to 11937000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 11937000.0 in Q1 2026, 11250000.0 in Q4 2025, and 15270000.0 in Q3 2025.